Tapering csDMARD or TNFi first: is the risk of flares different for ACPA-positive or ACPA-negative rheumatoid arthritis?

IF 5.1 2区医学 Q1 RHEUMATOLOGY RMD Open Pub Date : 2024-07-20 DOI:10.1136/rmdopen-2024-004258

Judith W Heutz, Agnes E M Looijen, Annette H M van der Helm-van Mil, Pascal H P de Jong, Elise van Mulligen

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

先逐步减少 csDMARD 或 TNFi：ACPA 阳性或 ACPA 阴性类风湿关节炎的复发风险是否不同？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

RMD Open RHEUMATOLOGY-

CiteScore

7.30

自引率

6.50%

发文量

205

审稿时长

14 weeks

期刊介绍： RMD Open publishes high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies that add to the literature are all considered.

期刊最新文献

Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European rheumatology registries. Association between musculoskeletal sonographic features and response to treatment in patients with psoriatic arthritis. Value of the central sensitisation inventory in patients with axial spondyloarthritis. Baseline and 2-year differences in spinal symptoms and spinal and hip mobility in early axial spondyloarthritis and non-axial spondyloarthritis chronic back pain patients. Disease response in rheumatoid arthritis across four biologic therapies associates with improvement in paraoxonase-1 activity and oxylipins.